Literature DB >> 18213635

Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.

Jielin Sun1, Ethan M Lange, Sarah D Isaacs, Wennuan Liu, Kathleen E Wiley, Leslie Lange, Henrik Gronberg, David Duggan, John D Carpten, Patrick C Walsh, Jianfeng Xu, Bao-Li Chang, William B Isaacs, S Lilly Zheng.   

Abstract

BACKGROUND: Multiple variants in three regions at 8q24 are consistently found to be associated with prostate cancer (PCa) risk in population-based association studies. The role that these variants may play in familial prostate cancer risk has not been extensively investigated.
METHODS: We evaluated 12 SNPs at three 8q24 regions using population-based association and family-based linkage and association methods in hereditary PCa (HPC) probands and their families, non-HPC patients, and unaffected screened controls, all recruited at Johns Hopkins Hospital.
RESULTS: For multiple variants in Region 1 (e.g., rs1447295) and Region 2 (e.g., rs16901979), we found statistically significantly higher frequencies of previously identified risk alleles and genotypes in HPC probands than in unaffected controls. Furthermore, in Region 2 the risk alleles were statistically significantly more frequent in HPC probands than in non-HPC patients. Family-based transmission tests found risk alleles of SNPs in Region 2, but not in Regions 1 and 3, were significantly over-transmitted to affected men in these families. We found little evidence supporting PCa linkage at 8q24 in 168 HPC families, in part explained by the observation of multiple, different risk allele-containing haplotypes segregating in the vast majority of these families.
CONCLUSIONS: Our study further supports the presence of PCa susceptibility loci at 8q24, particular at Region 2, and also provides evidence that these SNPs play an important role in familial prostate cancer. Large family-based studies are needed to confirm our novel findings.

Entities:  

Mesh:

Year:  2008        PMID: 18213635     DOI: 10.1002/pros.20695

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  22 in total

1.  Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.

Authors:  Sarah M Troutman; Tristan M Sissung; Cheryl D Cropp; David J Venzon; Shawn D Spencer; Bamidele A Adesunloye; Xuan Huang; Fatima H Karzai; Douglas K Price; William D Figg
Journal:  Oncologist       Date:  2012-03-01

Review 2.  Identification of new genetic risk factors for prostate cancer.

Authors:  Michelle Guy; Zsofia Kote-Jarai; Graham G Giles; Ali Amin Al Olama; Sarah K Jugurnauth; Shani Mulholland; Daniel A Leongamornlert; Stephen M Edwards; Jonathan Morrison; Helen I Field; Melissa C Southey; Gianluca Severi; Jenny L Donovan; Freddie C Hamdy; David P Dearnaley; Kenneth R Muir; Charmaine Smith; Melisa Bagnato; Audrey T Ardern-Jones; Amanda L Hall; Lynne T O'Brien; Beatrice N Gehr-Swain; Rosemary A Wilkinson; Angela Cox; Sarah Lewis; Paul M Brown; Sameer G Jhavar; Malgorzata Tymrakiewicz; Artitaya Lophatananon; Sarah L Bryant; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Cyril Fisher; Charles Jameson; Colin S Cooper; Dallas R English; John L Hopper; David E Neal; Douglas F Easton; Rosalind A Eeles
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

Review 3.  Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

4.  Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis.

Authors:  Claire L Simpson; Cheryl D Cropp; Tiina Wahlfors; Asha George; Marypat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Teuvo Tammela; Johanna Schleutker; Joan E Bailey-Wilson
Journal:  Eur J Hum Genet       Date:  2012-09-05       Impact factor: 4.246

5.  Common variants at 8q24 are associated with prostate cancer risk in Serbian population.

Authors:  Ana S Branković; Goran N Brajušković; Jovan D Mirčetić; Zorana Z Nikolić; Predrag B Kalaba; Vinka D Vukotić; Saša M Tomović; Snežana J Cerović; Zoran A Radojičić; Dušanka L J Savić-Pavićević; Stanka P Romac
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

6.  Number of prostate cancer risk alleles may identify possibly 'insignificant' disease.

Authors:  Brian T Helfand; Stacy Loeb; Donghui Kan; William J Catalona
Journal:  BJU Int       Date:  2010-12       Impact factor: 5.588

Review 7.  Prostate cancer in young men: an important clinical entity.

Authors:  Claudia A Salinas; Alex Tsodikov; Miriam Ishak-Howard; Kathleen A Cooney
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

8.  Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.

Authors:  Sungshim Lani Park; Shen-Chih Chang; Lin Cai; Carlos Cordon-Cardo; Bao-Guo Ding; Sander Greenland; Shehnaz K Hussain; Qingwu Jiang; Simin Liu; Ming-Lan Lu; Jenny T Mao; Hal Morgenstern; Li-Na Mu; Leslie J Ng; Allan Pantuck; Jianyu Rao; Victor E Reuter; Donald P Tashkin; Nai-Chieh Y You; Can-Qing Yu; Shun-Zhang Yu; Jin-Kou Zhao; Arie Belldegrun; Zuo-Feng Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  Family-based samples can play an important role in genetic association studies.

Authors:  Ethan M Lange; Jielin Sun; Leslie A Lange; S Lilly Zheng; David Duggan; John D Carpten; Henrik Gronberg; William B Isaacs; Jianfeng Xu; Bao-Li Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

10.  Significance of common variants on human chromosome 8q24 in relation to the risk of prostate cancer in native Japanese men.

Authors:  Miao Liu; Takayuki Kurosaki; Motofumi Suzuki; Yutaka Enomoto; Hiroaki Nishimatsu; Tomio Arai; Motoji Sawabe; Takayuki Hosoi; Yukio Homma; Tadaichi Kitamura
Journal:  BMC Genet       Date:  2009-07-14       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.